Entering text into the input field will update the search result below

Trillium Therapeutics reports Q1 results

  • Trillium Therapeutics (NASDAQ:TRIL): Q1 net loss of $7.2M.
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
TRIL--
Trillium Therapeutics Inc.